Role of free radicals in viral pathogenesis and mutation

Reviews in Medical Virology

Volumn 11, Issue 2, 2001, Pages 87-101

  Akaike, Takaaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; NITRIC OXIDE; OXYGEN RADICAL;

IMMUNOPATHOLOGY; INFLUENZA VIRUS; MOLECULAR EVOLUTION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW; VIRUS MUTATION; VIRUS PATHOGENESIS;

ANIMALS; HUMANS; MICE; MUTATION; NITRIC OXIDE; SUPEROXIDES; VIRUS DISEASES; VIRUSES;

EID: 0035056751     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.303     Document Type: Review

References (138)

1. Specific amino acid (L-arginine) requirement for microbiostatic activity of murine macrophages
2. Role of nitric oxide synthesis in macrophage antimicrobial activity
3. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens
4. Resistance to nitric oxide in Mycobacterium avium complex and its implication in pathogenesis
5. Role of nitric oxide in parasitic infections
6. Induction of nitric oxide synthesis and xanthine oxidase and their role in the antimicrobial mechanism against Salmonella typhimurium in mice
7. Active oxygen species and the functions of phagocytic leukocytes
8. The L-arginine-nitric oxide pathway
9. Mammalian nitric oxide synthase
10. Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/ NO through a radical reaction
11. Oxygen free radicals as pathogenic molecules in viral diseases
12. Free radicals in viral pathogenesis: Molecular mechanisms involving superoxide and NO
13. Nitric oxide in influenza
14. Pathophysiological effects of high-output production of nitric oxide
15. Nitric oxide and virus infection
16. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
17. Nitric oxide, superoxide and peroxynitrite: The good, the bad, and the ugly
18. Nitric oxide regulation of tissue free radical injury
19. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase
20. Tyrosine nitration by peroxynitrite formed from nitric oxide and superoxide generated by xanthine oxidase
21. Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite
22. DNA damage induced by peroxynitrite: Subsequent biological effects
23. Formation of 8-nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal from DNA by depurination
24. Disorders of phagocyte function
25. Two forms of autosomal chronic granulomatous disease lack distinct neutrophil cytosol factors
26. Oxygen, ischemia and inflammation
27. Superoxide radical and superoxide dismutases
28. Oxygen-derived free radicals in postischemic tissue injury
29. - generation by xanthine oxidase of pathogenesis of influenza virus infection in mice radicals
30. Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD
31. Pathogenesis of cytomegalovirus-associated pneumonitis in ICR mice: Possible involvement of superoxide radicals
32. The biology of oxygen radicals
33. Oxygen toxicity, oxygen radicals, transition metals and disease
34. Virus-induced formation of reactive oxygen intermediates in phagocytic cells
35. Oxidative stress during viral infection: A review
36. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HSV-1)-infected monocytes: Implications for HIV-associated neurological disease
37. Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation
38. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases
39. Severity of neurological signs and degree of inflammatory lesions in the brains of the rats with Borna disease correlate with the induction of nitric oxide synthase
40. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase
41. Effect of neurotropic virus infection on neuronal and inducible nitric oxide synthase activity in rat brain
42. Expression of nitric oxide synthase in a murine model of viral myocarditis induced by coxsackievirus B3
43. Pathogenesis of influenza virus-induced pneumonia: Involvement of both nitric oxide and oxygen radicals
44. Role of nitric oxide in pathogenesis of herpes simplex virus encephalitis in rats
45. Viral mutation accelerated by nitric oxide production during infection in vivo
46. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages
47. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β
48. Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages
49. 2) in murine bone marrow-derived macrophages
50. Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line
51. Coinduction of nitric oxide synthase and arginase I in cultured rat peritoneal macrophages and rat tissues in vivo by lipopolysaccharide
52. Mechanisms and structural determinants of HIV-1 coat protein, gp41-induced neurotoxicity
53. Human immunodeficiency virus-1-infected macrophages induce inducible nitric oxide synthase and nitric oxide (NO) production on astrocytes: Astrocytic NO as a possible mediator of neuronal damage in acquired immunodeficiency syndrome
54. Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation: Pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex
55. Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy
56. Respiratory syncytial virus infection of human respiratory epithelial cells enhances inducible nitric oxide synthase gene expression
57. Central role of double-stranded RNA-activated protein kinase in microbial induction of nitric oxide synthase
58. Inducible nitric oxide synthase: What difference does it make?
59. Identification of nitric oxide synthase as a protective locus against tuberculosis
60. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase
61. Reactive nitrogen intermediates and the pathogensis of Salmonella and mycobacteria
62. Cooperation between reactive oxygen and nitrogen intermediates in killing of Rhodococcus equi by activated macrophages
63. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo
64. Pronounced enhancement of NO-dependent antimicrobial action by an NO-oxidizing agent, imidazolineoxyl N-oxide
65. Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model
66. Helicobacter pylori urease suppresses bactericidal activity of peroxynitrite via carbon dioxide production
67. 1-protease inhibitor after S-nitrosylation: Inhibition of cysteine protease and antibacterial activity
68. Biochemistry of nitric oxide and its redox-activated forms
69. Mechanisms of biological S-nitrosation and its measurement
70. Evidence for an antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication
71. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation
72. Nitric oxide down-regulates Epstein-Barr virus reactivation in epithelial cell lines
73. An antiviral mechanism of nitric oxide: Inhibition of a viral proteinase
74. Identification of nitric oxide synthase 2 as an innate resistance locus against ectromelia virus infection
75. Inducible nitric oxide synthase protection against coxsackievirus pancreatitis
76. IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-γ and nitric oxide synthetase 2
77. Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice
78. Inducible nitric-oxide synthase plays a minimal role in lymphocytic choriomeningitis virus-induced, T cell-mediated protective immunity and immunopathology
79. Coronavirus-induced demyelination occurs in the absence of inducible nitric oxide synthase
80. Inhibitory activity of constitutive nitric oxide on the expression of alpha/beta interferon genes in murine peritoneal macrophages
81. Nitric oxide and viral infection: No antiviral activity against a flavivirus in vitro, and evidence for contribution to pathogenesis in experimental infection in vivo
82. Suppression of herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2)
83. Treatment of experimental viral myocarditis with interleukin-10
84. Prevention of encephalomyocarditis virus-induced diabetes in mice by inhibition of the tyrosine kinase signaling pathway and subsequent suppression of nitric oxide production in macrophages
85. The severity of Murray Valley encephalitis in mice is linked to neutrophil infiltration and inducible nitric oxide synthase activity in the central nervous system
86. Inhibitory effects of recombinant manganese superoxide dismutase on influenza virus infections in mice
87. An essential role of free radicals and derived species in signal transduction
88. Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo
89. Nitric oxide inhibits CPP32-like activity under redox regulation
90. Nitric oxide induces tyrosine nitration and release of cytochrome c preceding an increase of mitochondrial transmembrane potential in macrophages
91. Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: A novel mechanism of procollagenase activation involving nitric oxide
92. The reaction of ebselen with peroxynitrite
93. Mutation caused by human phagocytes
94. The composition of proteins of chemically evoked mutants of TMV RNA
95. Mutagenicity of alkyl and nitroso-alkyl compounds acting on tobacco mosaic virus and its RNA
96. Mutation of type 3 poliovirus with nitrous acid
97. Induction of Newcastle disease virus mutants with nitrous acid
98. Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis
99. Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells
100. Mutagenesis associated with nitric oxide production in macrophages
101. Mutagenesis associated with nitric oxide production in transgenic SJL mice
102. Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein
103. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism
104. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases
105. Reduced oxygen species, mutation, induction and cancer initiation
106. Chemical and physical carcinogenesis: Advances and perspectives for the 1990s
107. Active oxygen species as factors in multistage carcinogenesis
108. Oxidants, antioxidants, and the degenerative diseases of aging
109. RNA virus fitness
110. Rapid evolution of RNA genomes
111. Rates of spontaneous mutation among RNA viruses
112. Rates of spontaneous mutation
113. Determination of the mutation rate of a retrovirus
114. Increase in the frequency of hepadnavirus DNA integrations by oxidative DNA damage and inhibition of DNA repair
115. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates
116. Glutathione peroxidase protects mice from viral-induced myocarditis
117. Rapid evolution of viral RNA genomes
118. The mutation rate and variability of eukaryotic viruses: An analytical review
119. Similar frequencies of antigenic variants in Sendai, vesicular stomatitis, and influenza A viruses
120. Monoclonal antibodies of the HN glucoprotein of Newcastle disease virus. Biological characterization and use for strain comparisons
121. Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression
122. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells
123. Altered immune responses in mice lacking inducible nitric oxide synthase
124. Nitric oxide in autoimmune disease: Cytotoxic or regulatory mediator?
125. Immunology taught by viruses
126. Different rules govern help for cytotoxic T cells and B cells
127. Mice lacking inducible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses
128. Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages
129. Bruton's tyrosine kinase deficiency in macrophages inhibits nitric oxide generation leading to enhancement of IL-12 induction
130. Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: Suppressive effects of IL-12 boost are mediated by nitric oxide
131. A case for cytokines as effector molecules in the resolution of virus infection
132. + T cells
133. + T helper type 2 T lymphocytes do not promote recovery from experimental virus infection
134. Response to influenza infection in mice with a targeted disruption in the interferon γ gene
135. Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection
136. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro
137. Reactive nitrogen species and tyrosine nitration in the respiratory tract: Epiphenomena or a pathobiologic mechanism of disease?
138. Introduction and overview